In addition, HER2+ BC, ER+HER2+BC, and non-TNBC BC patients showed significantly higher risk scores than HER2- BC, non-ER+HER2+BC, and TNBC BC patients, respectively (Figures 11I–L). The gene discussed is ERBB2; the disease is breast cancer.